M J Bolland

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. ncbi Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 67:270-5. 2007
  2. ncbi Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1020, New Zealand
    N Z Med J 121:18-29. 2008
  3. ncbi The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Am J Clin Nutr 86:959-64. 2007
  4. pmc Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
    Mark J Bolland
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    BMJ 336:262-6. 2008
  5. ncbi Does degree of baldness influence vitamin D status?
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Med J Aust 189:674-5. 2008
  6. ncbi Vitamin D supplementation and falls: a trial sequential meta-analysis
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand Electronic address
    Lancet Diabetes Endocrinol 2:573-80. 2014
  7. ncbi The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland 1142, New Zealand Electronic address
    Lancet Diabetes Endocrinol 2:307-20. 2014
  8. doi Testosterone levels following decreases in serum osteocalcin
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, 1142, New Zealand
    Calcif Tissue Int 93:133-6. 2013
  9. doi Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    J Clin Endocrinol Metab 97:1922-8. 2012
  10. doi Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 76:643-8. 2012

Collaborators

Detail Information

Publications60

  1. ncbi Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 67:270-5. 2007
    ..We have now addressed the question of whether there is accelerated BMD loss over time in HIV-infected men...
  2. ncbi Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1020, New Zealand
    N Z Med J 121:18-29. 2008
    ..We followed a group of postmenopausal women with asymptomatic PHPT for up to 10 years to determine whether they could be managed conservatively without parathyroidectomy...
  3. ncbi The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Am J Clin Nutr 86:959-64. 2007
    ..The effect of season on vitamin D status is often overlooked in studies of optimal vitamin D concentrations and in clinical practice...
  4. pmc Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
    Mark J Bolland
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    BMJ 336:262-6. 2008
    ..To determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women...
  5. ncbi Does degree of baldness influence vitamin D status?
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Med J Aust 189:674-5. 2008
    ..To determine the association, if any, between male-pattern hair loss (baldness) and serum 25-hydroxyvitamin D (25-OHD) levels...
  6. ncbi Vitamin D supplementation and falls: a trial sequential meta-analysis
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand Electronic address
    Lancet Diabetes Endocrinol 2:573-80. 2014
    ..Vitamin D supplementation is often recommended to prevent falls, although vitamin D trials and meta-analyses of these trials have reported conflicting results for this outcome. We aimed to assess if there was a need for further research...
  7. ncbi The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland 1142, New Zealand Electronic address
    Lancet Diabetes Endocrinol 2:307-20. 2014
    ..Vitamin D insufficiency is associated with many disorders, leading to calls for widespread supplementation. Some investigators suggest that more clinical trials to test the effect of vitamin D on disorders are needed...
  8. doi Testosterone levels following decreases in serum osteocalcin
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, 1142, New Zealand
    Calcif Tissue Int 93:133-6. 2013
    ..This provides reassurance that men receiving potent antiresorptive drugs are not at risk of iatrogenic hypogonadism...
  9. doi Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    J Clin Endocrinol Metab 97:1922-8. 2012
    ..In HIV-infected men, the antiresorptive effects of zoledronate persist for at least 2 yr after the second annual dose...
  10. doi Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 76:643-8. 2012
    ..We assessed BMD changes over the medium term in HIV-infected men already established on HAART at baseline...
  11. ncbi Should measurement of vitamin D and treatment of vitamin D insufficiency be routine in New Zealand?
    Mark J Bolland
    Bone and Joint Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    N Z Med J 125:83-91. 2012
    ..Therefore, a move away from routine vitamin D measurements seems sensible, though they are still indicated when investigating suspected metabolic bone disease or hypocalcaemia...
  12. doi Mortality and morbidity in Cushing's syndrome in New Zealand
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 75:436-42. 2011
    ..However, recent operative series suggest low morbidity and mortality for CS, whereas population-based surveys report elevated mortality rates. We investigated the mortality and morbidity of CS in New Zealand...
  13. doi Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    J Bone Miner Res 23:1304-8. 2008
    ..Randomized trials that address this issue should be performed...
  14. doi Bilateral transient osteoporosis of the hip in a young man
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    J Clin Densitom 11:339-41. 2008
    ..The management of this disorder including the possible indications for antiresorptive therapy is reviewed...
  15. ncbi The effects of seasonal variation of 25-hydroxyvitamin D on diagnosis of vitamin D insufficiency
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    N Z Med J 121:63-74. 2008
    ..To explore the effects of seasonal variation on the diagnosis of vitamin D sufficiency and to determine whether age, gender, and ethnicity modify these effects...
  16. ncbi Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    J Bone Miner Res 25:505-12. 2010
    ....
  17. doi Effect of osteoporosis treatment on mortality: a meta-analysis
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    J Clin Endocrinol Metab 95:1174-81. 2010
    ..Conclusions: Treatments for osteoporosis with established vertebral and nonvertebral fracture efficacy reduce mortality in older, frailer individuals with osteoporosis who are at high risk of fracture...
  18. doi Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines
    Mark J Bolland
    Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1142, New Zealand
    J Clin Endocrinol Metab 95:1856-60. 2010
    ..S.-based National Osteoporosis Foundation (NOF) and the U.K.-based National Osteoporosis Guidelines Group (NOGG) differ markedly in their approaches to treatment recommendations...
  19. doi Evaluation of the FRAX and Garvan fracture risk calculators in older women
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland 1142, New Zealand
    J Bone Miner Res 26:420-7. 2011
    ..The calibration varied, suggesting that the calculators should be validated in local cohorts before clinical use...
  20. doi Stable bone density in HAART-treated individuals with HIV: a meta-analysis
    Mark J Bolland
    Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    J Clin Endocrinol Metab 96:2721-31. 2011
    ..Longitudinal studies of bone mineral density (BMD) in HIV have reported conflicting results...
  21. pmc Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Am J Clin Nutr 94:1144-9. 2011
    ..Frequent use of personal, nonprotocol calcium supplements obscured an adverse effect of coadministered calcium and vitamin D (CaD) on cardiovascular risk in the Women's Health Initiative (WHI)...
  22. doi Vitamin D insufficiency and health outcomes over 5 y in older women
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Am J Clin Nutr 91:82-9. 2010
    ..However, some studies did not control for confounding factors such as age or seasonal variation of 25-hydroxyvitamin D [25(OH)D]...
  23. pmc Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report
    Mark J Bolland
    Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1020, New Zealand
    Ann Clin Microbiol Antimicrob 7:3. 2008
    ..People infected with human immunodeficiency virus are frequently treated with medications that can induce or inhibit cytochrome P450 enzymes...
  24. ncbi Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective
    Mark Bolland
    Department of Medicine, University of Auckland
    N Z Med J 119:U2339. 2006
    ..The aim of this article is to put the risks of osteonecrosis of the jaw into context with the benefits of bisphosphonate treatment in these clinical scenarios...
  25. ncbi Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations
    Mark J Bolland
    Department of Medicine, University of Auckland, New Zealand
    J Bone Miner Res 22:411-5. 2007
    ..At any given age, the offspring were less likely to be diagnosed with Paget's disease and had less severe disease than their parents...
  26. ncbi Determinants of vitamin D status in older men living in a subtropical climate
    M J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    Osteoporos Int 17:1742-8. 2006
    ....
  27. ncbi Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 67:259-64. 2007
    ..We hypothesized that these findings might be explained by effects of these variables on vitamin D binding protein (DBP) levels. We set out to determine the relationships between DBP and gender, 25OHD, body weight and body composition...
  28. ncbi Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy
    Mark J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 65:191-7. 2006
    ..We sought to determine whether BMD in HIV-infected men treated with HAART for at least 3 months is different from that in healthy controls, and, if so, what HIV-related factors might explain this finding...
  29. ncbi Heterophile antibodies may cause falsely lowered serum cortisol values
    M J Bolland
    Department of Medicine, University of Auck and, Private Bag 92 019, Auckland 1020, New Zealand
    J Endocrinol Invest 28:643-5. 2005
    ..We describe a case where interference by heterophile antibodies in a cortisol immunoassay led to a falsely lowered serum cortisol level...
  30. ncbi CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    J Clin Endocrinol Metab 92:4522-8. 2007
    ..The cross-sectional studies may have been confounded by the failure to control for low body weight in HIV-infected patients...
  31. ncbi Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland Private Bag 92 019, Auckland 1020, New Zealand
    Bone 38:317-21. 2006
    ..This association between fat mass and PTH might contribute to the association between primary hyperparathyroidism and increased body weight...
  32. ncbi Association between primary hyperparathyroidism and increased body weight: a meta-analysis
    Mark J Bolland
    Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1020, New Zealand
    J Clin Endocrinol Metab 90:1525-30. 2005
    ....
  33. ncbi Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial
    Mark J Bolland
    Department of Medicine, University of Auckland, and Department of Infectious Diseases, Auckland Hospital, New Zealand
    J Clin Endocrinol Metab 92:1283-8. 2007
    ..Recent studies have reported low bone mineral density (BMD) in HIV-infected patients. Annual iv administration of 4 mg zoledronate has been shown to increase BMD and suppress bone turnover in postmenopausal women...
  34. ncbi Determinants of vitamin D status in older women living in a subtropical climate
    Jenny A Lucas
    Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    Osteoporos Int 16:1641-8. 2005
    ..Our findings support the suggestion that vitamin D supplementation should become standard practice in this population of women, particularly during winter...
  35. doi The impact of dietary calcium intake and vitamin D status on the effects of zoledronate
    S Bourke
    Department of Rheumatology, Auckland City Hospital, Auckland, New Zealand
    Osteoporos Int 24:349-54. 2013
    ....
  36. ncbi The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women
    M J Bolland
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Osteoporos Int 18:479-86. 2007
    ..The improvements in bone density seen in the first 2 years were sustained throughout the extension study. Thiazides provide a further option in the prevention of postmenopausal bone loss...
  37. doi Cardiovascular effects of calcium supplementation
    I R Reid
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Osteoporos Int 22:1649-58. 2011
    ..Since food sources have not been associated with adverse cardiovascular effects, they may be preferable. Available evidence suggests that other osteoporosis treatments are still effective without calcium co-administration...
  38. doi Effect of calcium supplementation on hip fractures
    I R Reid
    Faculty of Medical and Health Sciences, University of Auckland, Private Bag, 92019 Auckland, New Zealand
    Osteoporos Int 19:1119-23. 2008
    ..In addition, those at risk should be looking to other agents with a proven capacity to prevent hip fractures, such as bisphosphonates...
  39. doi Calcium supplementation and vascular disease
    I R Reid
    Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Climacteric 11:280-6. 2008
    ..Further research in this area is a high priority on the women's health agenda...
  40. ncbi Randomized controlled trial of calcium in healthy older women
    Ian R Reid
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Am J Med 119:777-85. 2006
    ..However, these effects are small, it is unknown whether they are sustained with long-term use, they have not been shown with intention-to-treat analyses, and the evidence for fracture prevention with calcium monotherapy is inconsistent...
  41. pmc Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
    Mark J Bolland
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92 019, Auckland 1142, New Zealand
    BMJ 341:c3691. 2010
    ..To investigate whether calcium supplements increase the risk of cardiovascular events...
  42. doi Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men
    Ian R Reid
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Arch Intern Med 168:2276-82. 2008
    ..There is no consistent evidence, to our knowledge, that calcium supplementation affects bone mineral density (BMD) in men, despite male osteoporosis being a common clinical problem...
  43. doi The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women
    Andrew Grey
    Department of Medicine, University of Auckland, Private Bag 92 019, Auckland, New Zealand
    J Clin Endocrinol Metab 94:538-44. 2009
    ..Annual iv administration of 5 mg zoledronate decreases fracture risk. The optimal dosing interval of 5 mg zoledronate is not known...
  44. ncbi Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
    Ian R Reid
    Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand
    Bone 41:318-20. 2007
    ....
  45. doi Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial
    Ian R Reid
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Am J Clin Nutr 91:131-9. 2010
    ..Calcium supplementation has been suggested to have beneficial effects on serum lipids, blood pressure, and body weight, but these possibilities have not been rigorously assessed in men...
  46. doi Does calcium supplementation increase cardiovascular risk?
    Ian R Reid
    Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Clin Endocrinol (Oxf) 73:689-95. 2010
    ....
  47. doi The Auckland calcium study: 5-year post-trial follow-up
    L T Radford
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Osteoporos Int 25:297-304. 2014
    ..There was no increased risk of cardiovascular events after discontinuation of calcium...
  48. doi The effect of treatments for osteoporosis on mortality
    A Grey
    Department of Medicine, University of Auckland, Auckland, New Zealand
    Osteoporos Int 24:1-6. 2013
    ....
  49. doi A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
    I M Holdaway
    Department of Endocrinology, Greenlane Clinical Centre and Auckland City Hospital, PO Box 92189, Auckland 1142, New Zealand
    Eur J Endocrinol 159:89-95. 2008
    ..A meta-analysis of mortality studies in acromegaly has thus been performed to assess the effect of lowering serum GH and IGF-I on survival...
  50. doi Role of ultrasound in the assessment of nodular thyroid disease
    S Bastin
    Department of Paediatric Radiology, Starship Children s Hospital, Auckland, New Zealand
    J Med Imaging Radiat Oncol 53:177-87. 2009
    ..Recent guidelines endorse this approach of using combinations of US features to guide nodule selection for fine needle aspiration...
  51. ncbi A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests
    James S Davidson
    Department of Chemical Pathology, LabPlus, Auckland City Hospital, Auckland, New Zealand
    Ann Clin Biochem 43:237-9. 2006
    ..Measurement of CBG concentration and calculation of free cortisol or free cortisol index can help avoid false interpretations of dynamic tests of the HPA axis based on plasma total cortisol...
  52. ncbi Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole
    Mark J Bolland
    Department of Endocrinology, Auckland Hospital, Auckland, New Zealand
    Ann Pharmacother 38:46-9. 2004
    ..To report a case of an interaction between inhaled corticosteroids and itraconazole causing iatrogenic Cushing's syndrome and provide a review of the relevant literature...
  53. pmc Osteonecrosis of the jaw and bisphosphonates: editorial was confusing
    Mark J Bolland
    BMJ 333:1122-3. 2006
  54. ncbi Calcium supplementation and cancer incidence
    Mark J Bolland
    Am J Clin Nutr 87:792-3; author reply 793-4. 2008
  55. ncbi Defining vitamin D deficiency
    Mark J Bolland
    N Z Med J 120:U2760. 2007
  56. ncbi Re: Calcium supplementation does not increase mortality
    Mark J Bolland
    Med J Aust 189:55; author reply 55-6. 2008
  57. ncbi Ashburton once again
    Mark J Bolland
    N Z Med J 116:U338. 2003